The transcription factor XBP1s restores hippocampal synaptic plasticity and memory by control of the Kalirin-7 pathway in Alzheimer model

Molecular Psychiatry - Tập 22 Số 11 - Trang 1562-1575 - 2017
Moustapha Cissé1, Eric Duplan1, Thomas Lorivel1, Julie Dunys1, Charlotte Bauer1, Xavier Meckler1, Yannis Gerakis1, Inger Lauritzen1, Frédéric Checler1
1Université de Nice-Sophia-Antipolis, Institut de Pharmacologie Moléculaire et Cellulaire, CNRS-UMR7275, Sophia-Antipolis, Valbonne, France

Tóm tắt

Từ khóa


Tài liệu tham khảo

Busquets-Garcia A, Gomis-Gonzalez M, Guegan T, Agustin-Pavon C, Pastor A, Mato S et al. Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nat Med 2013; 19: 603–607.

Mukai J, Dhilla A, Drew LJ, Stark KL, Cao L, MacDermott AB et al. Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nat Neurosci 2008; 11: 1302–1310.

Hayashi-Takagi A, Takaki M, Graziane N, Seshadri S, Murdoch H, Dunlop AJ et al. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat Neurosci 2010; 13: 327–332.

Jimenez-Mateos EM, Engel T, Merino-Serrais P, McKiernan RC, Tanaka K, Mouri G et al. Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat Med 2012; 18: 1087–1094.

Wei W, Nguyen LN, Kessels HW, Hagiwara H, Sisodia S, Malinow R . Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nat Neurosci 2010; 13: 190–196.

Zhou YD, Lee S, Jin Z, Wright M, Smith SE, Anderson MP . Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Nat Med 2009; 15: 1208–1214.

Blennow K, de Leon MJ, Zetterberg H . Alzheimer's disease. Lancet 2006; 368: 387–403.

Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ . Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 2007; 68: 1501–1508.

Um JW, Kaufman AC, Kostylev M, Heiss JK, Stagi M, Takahashi H et al. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein. Neuron 2013; 79: 887–902.

Mairet-Coello G, Courchet J, Pieraut S, Courchet V, Maximov A, Polleux F . The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Abeta oligomers through Tau phosphorylation. Neuron 2013; 78: 94–108.

Li S, Jin M, Zhang D, Yang T, Koeglsperger T, Fu H et al. Environmental novelty activates beta2-adrenergic signaling to prevent the impairment of hippocampal LTP by Abeta oligomers. Neuron 2013; 77: 929–941.

Segal M . Dendritic spines and long-term plasticity. Nat Rev Neurosci 2005; 6: 277–284.

Chen Y, Rex CS, Rice CJ, Dube CM, Gall CM, Lynch G et al. Correlated memory defects and hippocampal dendritic spine loss after acute stress involve corticotropin-releasing hormone signaling. Proc Natl Acad Sci USA 2010; 107: 13123–13128.

Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K . XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 2001; 107: 881–891.

Hetz C, Mollereau B . Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat Rev Neurosci 2014; 15: 233–249.

Paschen W, Yatsiv I, Shoham S, Shohami E . Brain trauma induces X-box protein 1 processing indicative of activation of the endoplasmic reticulum unfolded protein response. J Neurochem 2004; 88: 983–992.

Hayashi A, Kasahara T, Iwamoto K, Ishiwata M, Kametani M, Kakiuchi C et al. The role of brain-derived neurotrophic factor (BDNF)-induced XBP1 splicing during brain development. J Biol Chem 2007; 282: 34525–34534.

Sutton MA, Schuman EM . Local translational control in dendrites and its role in long-term synaptic plasticity. J Neurobiol 2005; 64: 116–131.

Mandela P, Ma XM . Kalirin, a key player in synapse formation, is implicated in human diseases. Neural Plast 2012; 2012: 728161.

Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J et al. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 2001; 276: 21562–21570.

Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003; 39: 409–421.

Guillot-Sestier MV, Sunyach C, Druon C, Scarzello S, Checler F . The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo. J Biol Chem 2009; 284: 35973–35986.

Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002; 416: 535–539.

Ma XM, Kiraly DD, Gaier ED, Wang Y, Kim EJ, Levine ES et al. Kalirin-7 is required for synaptic structure and function. J Neurosci 2008; 28: 12368–12382.

Ma XM, Wang Y, Ferraro F, Mains RE, Eipper BA . Kalirin-7 is an essential component of both shaft and spine excitatory synapses in hippocampal interneurons. J Neurosci 2008; 28: 711–724.

Penzes P, Johnson RC, Alam MR, Kambampati V, Mains RE, Eipper BA . An isoform of kalirin, a brain-specific GDP/GTP exchange factor, is enriched in the postsynaptic density fraction. J Biol Chem 2000; 275: 6395–6403.

Xin X, Wang Y, Ma XM, Rompolas P, Keutmann HT, Mains RE et al. Regulation of Kalirin by Cdk5. J Cell Sci 2008; 121: 2601–2611.

Kiraly DD, Lemtiri-Chlieh F, Levine ES, Mains RE, Eipper BA . Kalirin binds the NR2B subunit of the NMDA receptor, altering its synaptic localization and function. J Neurosci 2011; 31: 12554–12565.

Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, Hamada K et al. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenicmodel. Brain Res 2008; 1216: 92–103.

Clinton LK, Billings LM, Green KN, Caccamo A, Ngo J, Oddo S et al. Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. Neurobiol Dis 2007; 28: 76–82.

Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D . Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 2002; 295: 868–872.

Duplan E, Giaime E, Viotti J, Sevalle J, Corti O, Brice A et al. ER-stress-associated functional link between Parkin and DJ-1 via a transcriptional cascade involving the tumor suppressor p53 and the spliced X-box binding protein XBP-1. J Cell Sci 2013; 126: 2124–2133.

Cisse M, Halabisky B, Harris J, Devidze N, Dubal DB, Sun B et al. Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature 2011; 469: 47–52.

Lauritzen I, Pardossi-Piquard R, Bauer C, Brigham E, Abraham JD, Ranaldi S et al. The beta-secretase-derived C-terminal fragment of betaAPP, C99, but not Abeta, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus. J Neurosci 2012; 32: 16243–16255a.

Mains RE, Kiraly DD, Eipper-Mains JE, Ma XM, Eipper BA . Kalrn promoter usage and isoform expression respond to chronic cocaine exposure. BMC Neurosci 2011; 12: 20.

Penzes P, Johnson RC, Sattler R, Zhang X, Huganir RL, Kambampati V et al. The neuronal Rho-GEF Kalirin-7 interacts with PDZ domain-containing proteins and regulates dendritic morphogenesis. Neuron 2001; 29: 229–242.

Xie Z, Srivastava DP, Photowala H, Kai L, Cahill ME, Woolfrey KM et al. Kalirin-7 controls activity-dependent structural and functional plasticity of dendritic spines. Neuron 2007; 56: 640–656.

Youn H, Jeoung M, Koo Y, Ji H, Markesbery WR, Ji I et al. Kalirin is under-expressed in Alzheimer's disease hippocampus. J Alzheimers Dis 2007; 11: 385–397.

Murray PS, Kirkwood CM, Gray MC, Ikonomovic MD, Paljug WR, Abrahamson EE et al. beta-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis. Neurobiol Aging 2012; 33: 2807–2816.

Penzes P, Beeser A, Chernoff J, Schiller MR, Eipper BA, Mains RE et al. Rapid induction of dendritic spine morphogenesis by trans-synaptic ephrinB-EphB receptor activation of the Rho-GEF kalirin. Neuron 2003; 37: 263–274.

Ma XM, Huang J, Wang Y, Eipper BA, Mains RE . Kalirin, a multifunctional Rho guanine nucleotide exchange factor, is necessary for maintenance of hippocampal pyramidal neuron dendrites and dendritic spines. J Neurosci 2003; 23: 10593–10603.

Murata Y, Constantine-Paton M . Postsynaptic density scaffold SAP102 regulates cortical synapse development through EphB and PAK signaling pathway. J Neurosci 2013; 33: 5040–5052.

Reinhardt S, Schuck F, Grosgen S, Riemenschneider M, Hartmann T, Postina R et al. Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease. FASEB J 2014; 28: 978–997.

Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP et al. Metabolic regulation of brain Abeta by neprilysin. Science 2001; 292: 1550–1552.

Shirotani K, Tsubuki S, Iwata N, Takaki Y, Harigaya W, Maruyama K et al. Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases. J Biol Chem 2001; 276: 21895–21901.

Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun X et al. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 2003; 40: 1087–1093.

Caccamo A, Oddo S, Sugarman MC, Akbari Y, LaFerla FM . Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders. Neurobiol Aging 2005; 26: 645–654.

Choi DS, Wang D, Yu GQ, Zhu G, Kharazia VN, Paredes JP et al. PKCepsilon increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice. Proc Natl Acad Sci USA 2006; 103: 8215–8220.

Mueller-Steiner S, Zhou Y, Arai H, Roberson ED, Sun B, Chen J et al. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Neuron 2006; 51: 703–714.

Saito T, Iwata N, Tsubuki S, Takaki Y, Takano J, Huang SM et al. Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation. Nat Med 2005; 11: 434–439.

Nolt MJ, Lin Y, Hruska M, Murphy J, Sheffler-Colins SI, Kayser MS et al. EphB controls NMDA receptor function and synaptic targeting in a subunit-specific manner. J Neurosci 2011; 31: 5353–5364.

Kayser MS, McClelland AC, Hughes EG, Dalva MB . Intracellular and trans-synaptic regulation of glutamatergic synaptogenesis by EphB receptors. J Neurosci 2006; 26: 12152–12164.

He Y, Sun S, Sha H, Liu Z, Yang L, Xue Z et al. Emerging roles for XBP1, a sUPeR transcription factor. Gene Expr 2010; 15: 13–25.

Hetz C, Martinon F, Rodriguez D, Glimcher LH . The unfolded protein response: integrating stress signals through the stress sensor IRE1alpha. Physiol Rev 2011; 91: 1219–1243.

Martinez G, Vidal RL, Mardones P, Serrano FG, Ardiles AO, Wirth C et al. Regulation of Memory Formation by the Transcription Factor XBP1. Cell Rep 2016; 14: 1382–1394.

Postina R, Schroeder A, Dewachter I, Bohl J, Schmitt U, Kojro E et al. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest 2004; 113: 1456–1464.

Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM . Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 2003; 24: 1063–1070.

Dineley KT, Bell KA, Bui D, Sweatt JD . beta -Amyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Biol Chem 2002; 277: 25056–25061.

Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM . Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009; 457: 1128–1132.

Kim T, Vidal GS, Djurisic M, William CM, Birnbaum ME, Garcia KC et al. Human LilrB2 is a beta-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model. Science 2013; 341: 1399–1404.

Pujadas L, Rossi D, Andres R, Teixeira CM, Serra-Vidal B, Parcerisas A et al. Reelin delays amyloid-beta fibril formation and rescues cognitive deficits in a model of Alzheimer's disease. Nat Commun 2014; 5: 3443.

Valdes P, Mercado G, Vidal RL, Molina C, Parsons G, Court FA et al. Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1. Proc Natl Acad Sci USA 2014; 111: 6804–6809.

Zuleta A, Vidal RL, Armentano D, Parsons G, Hetz C . AAV-mediated delivery of the transcription factor XBP1s into the striatum reduces mutant Huntingtin aggregation in a mouse model of Huntington's disease. Biochem Biophys Res Commun 2012; 420: 558–563.

Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL . Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 2007; 27: 2866–2875.

Heredia L, Helguera P, de Olmos S, Kedikian G, Sola Vigo F, LaFerla F et al. Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid beta-induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimer's disease. J Neurosci 2006; 26: 6533–6542.

Peterson TS, Camden JM, Wang Y, Seye CI, Wood WG, Sun GY et al. P2Y2 nucleotide receptor-mediated responses in brain cells. Mol Neurobiol 2010; 41: 356–366.